Pinnacle Wealth Management Advisory Group, LLC
Position in ABVX — Abivax S.A.
CIK 1631864
RED BANK, NJ
Position in ABVX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$207,556
New position
Shares Held
1,864
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pinnacle Wealth Management Advisory Group, LLC holds $3,780,035 across 11 Biotechnology names. ABVX ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,415 | $1,865,925 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
874 | $390,275 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
6,115 | $345,436 | |
| 4 | INCY |
Incyte Corp
|
3,443 | $324,055 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
744 | $239,709 | |
| 6 | EXEL |
Exelixis, Inc.
|
5,195 | $222,813 | |
| 7 | ABVX |
Abivax S.A.
This page
|
1,864 | $207,556 | |
| 8 | GERN |
Geron Corp
|
44,466 | $66,254 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $207,556 | 1,864 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||